Home/Pipeline/vitaMedMD

vitaMedMD

Prenatal Vitamins

MarketedCommercial

Key Facts

Indication
Prenatal Vitamins
Phase
Marketed
Status
Commercial
Company

About TherapeuticsMD

TherapeuticsMD, Inc. is a public company that historically specialized in creating advanced hormone therapy solutions for women's health, particularly in contraception and menopause management. Its major achievement was securing FDA approval for two novel products: a long-acting reversible contraceptive and a bio-identical hormone therapy. After facing commercialization challenges and financial pressures, the company divested its prescription business to Mayne Pharma in 2022 and currently focuses on its over-the-counter prenatal vitamin, vitaMedMD, while exploring strategic alternatives for its remaining assets.

View full company profile